Abstract: A procedure to continuously produce a suspension of cellulose in aqueous N-methylmorpholine-N-oxide is characterized in that: (a) The cellulose is conveyed through a first shearing zone in the absence of N-methylmorpholine-N-oxide and is homogenized, and (b) the homogenized cellulose is conveyed through a second shearing zone after adding enough aqueous N-methylmorpholine-N-oxide for a suspension to result in a N-methylmorpholine-N-oxide content in the liquid phase of 70-80 weight percent after mixing, whereby the cellulose or suspension almost completely fills the available content cross-section in the shearing zones.
Abstract: An apparatus (10′) for detecting the surface topography of a cornea (24) of an eye (22) by dynamic or static projection of a pattern onto the surface of the cornea and detection of the pattern reflected by the cornea, providing preferably simultaneous detection of at least one optical property of a layer disposed beneath the cornea.
Type:
Grant
Filed:
July 30, 2001
Date of Patent:
August 5, 2003
Inventors:
Benedikt Jean, Thomas K. Bende, Adolf F. Fercher
Abstract: A method for detecting mutated alleles in an excess of wild type alleles in a sample by isolating sample DNA; amplifying a target DNA sequence; and separating mutated DNA sequences from wild type DNA sequences by virtue of the preferential binding of the wild type sequences to carrier-bound complementary oligonucleotides. The amplification and separation steps may be iterated through one or more additional cycles to enhance sensitivity.
Abstract: A system for the generation of live Bimavirus such as infectious bursal disease virus (IBDV), a segmented double-stranded (ds) RNA virus of the Bimaviridae family, using synthetic transcripts derived from cloned DNA has been developed. Independent full-length cDNA clones were constructed which contained the entire coding and non-coding regions of RNA segments A and B of IBDV, respectively. Synthetic RNAs of both segments were produced by in vitro transcriptions of linearized plasmids with T7 RNA polymerase. Transfection of Vero cells with combined plus-sense transcripts of both segments generated infectious virus as early as 36 hours post-transfection. The development of a reverse genetics system for dsRNA viruses will greatly facilitate studies of the regulation of viral gene expression pathogenesis, and design of a new generation of live and inactivated vaccines.
Type:
Grant
Filed:
April 30, 1999
Date of Patent:
July 22, 2003
Assignee:
University of Maryland Biotechnology Institute
Abstract: A process and apparatus for purifying one or more target substances from a source liquid, employing one or more cross-flow filter elements, and one or more types of chromatography resins, in combination, to provide purification with advantageous yield, product purity, and cost- and time-efficiency.
Abstract: A method and system for retrofitting an integrated scrubber to provide maximum oxygen content in a controlled decomposition oxidation (CDO) abatement process. The system includes a thermal/wet integrated scrubber, and a compressed air supply for supplying air to an oxygen separation device that separates the air into a nitrogen-enriched component and an oxygen-enriched component. The oxygen separation device utilizes a ceramic, metallic, carbonaceous or polymeric material to separate from the supplied air an oxygen-enriched component for introduction into the integrated scrubber. The integrated scrubber is equipped with a mechanical scraping device for continuous or intermittent removal of combustion deposits formed during the controlled decomposition oxidation process.
Type:
Grant
Filed:
December 18, 2001
Date of Patent:
July 22, 2003
Assignee:
Advanced Technology Materials, Inc.
Inventors:
Belynda G. Flippo, Robbert Vermuellen, Daniel O. Clark
Abstract: The present inventors have found that certain preparations containing LPS and/or lipid A variants, derivatives, and/or analogs demonstrate non-pyrogenic properties and exhibit anti-viral activities. In particular, non-pyrogenic preparations of LPS, lipid A, LPS antagonists and lipid A antagonists, and derivatives thereof induce &bgr; chemokine secretion, such as MIP-1&bgr;, but not proinflammatory cytokines, such as TNF&agr;, IL-1&bgr; and IL-6. Non-pyrogenic preparations of the invention have been demonstrated by the Applicant to suppress HIV replication in human peripheral blood monocytes, as described by way of example herein. The present invention provides preparations of LPS or lipid A variants, analogs and derivatives of decreased or absent pyrogenicity which can be used as therapeutics for the treatment or prevention of immunodeficiency virus infection and its consequences.
Type:
Grant
Filed:
March 27, 2000
Date of Patent:
July 22, 2003
Assignee:
University of Maryland Biotechnology Institute
Inventors:
David M. Hone, Richard Crowley, George Lewis
Abstract: The present invention relates to peptides of one or more portions of the human chorionic gonadotropin &bgr;-chain as well as methods of promoting hematopoiesis, using human chorionic gonadotropin, employing the &bgr;-chain of human chorionic gonadotropin, peptides containing a sequence of one or more portions of the &bgr;-chain of human chorionic gonadotropin and derivatives and analogues thereof. The invention further relates to fractions of sources and or perparations of human chorionic gonadotropin, such as fractions of humna early pregnancy urine, which fractions have pro-hematopoietic activity. The present invention further relates to pharmaceutical compositions for promoting hematopoiesis.
Type:
Grant
Filed:
September 29, 2000
Date of Patent:
July 22, 2003
Assignee:
University of Maryland Biotechnology Institute
Inventors:
Robert C. Gallo, Joseph Bryant, Yanto Lunardi-Iskandar
Abstract: Novel pest control compounds, compositions comprising such compounds, and methods for using such compounds and compositions against a variety of pests, including pests of agricultural crops.
Type:
Grant
Filed:
April 21, 1999
Date of Patent:
July 15, 2003
Assignees:
University of Florida Research Foundation, Inc., Insect Biotechnology, Inc.
Inventors:
John Bennett, Alan Brandt, Dov Borovsky
Abstract: The present invention relates to a vector which is suitable for gene prophylaxis/gene therapy, containing a nucleic acid fragment coding for a mutated prion protein. The invention further relates to a vaccination agent which contains the vector in addition to the usual auxiliary agents, and to the use of the vector or vaccination agent in the prophylaxis and/or treatment of prion diseases. The invention further relates to non-human mammals, e.g. working animals, which are resistant to prion infections.
Type:
Grant
Filed:
November 3, 1999
Date of Patent:
July 15, 2003
Assignee:
Deutsches Krebsforschungszentrum Stiftung des Offentilichen
Rechts
Abstract: An FM transmitter and power supply/charging assembly electrically coupleable with an MP3 player. The assembly includes a modular docking unit having a main body portion with a docking cavity therein, wherein the main body portion contains the FM transmitter and power/charging circuitry, with coupling means in the docking cavity for connecting the MP3 player with the FM transmitter and power/charging circuitry, to accommodate FM transmission by the FM transmitter of audio content when played by the MP3 player in the docking cavity of the modular docking unit, and adapted for transmitting electrical power through the modular docking unit and the power/charging circuitry therein, for charging of a battery of the MP3 player and/or powering of the MP3 player.
Abstract: The present invention relates to a recirculating marine aquaculture process for production of a crab species, including (i) a broodstock conditioning, (ii) spawning, (iii) egg incubation, (iv) larval growth, (v) nursery post-larval growth, and (vi) grow-out of the crab to a final product weight, in which each stage (i)-(vi) of the process involves operation in an aqueous medium that is coupled in liquid recirculation relationship with waste component removal from the aqueous medium and returning purified aqueous medium to the external environment. The process involves operation in a closed, recirculating aquaculture system in which photoperiod, water temperature, water chemistry, and diet are optimized and then continuously monitored and controlled to obtain optimal production at each of the six phases (i)-(vi) of the life cycle.
Type:
Grant
Filed:
August 19, 2002
Date of Patent:
July 1, 2003
Assignee:
University of Maryland Biotechnology Institute
Abstract: Small heat shock proteins, e.g., Pyrococcus fuiosus (Pfu-sHSP), confer thermotolerance on cellular cultures and on proteins in cellular extracts during prolonged incubation at elevated temperature, demonstrating the ability to protect cellular proteins and maintain cellular viability under heat stress conditions. Such heat shock proteins are effective to combat enzymatic aggregation and intracellular precipitation during heat stress, and thereby enable enhancement of the utility and stability of enzymes in various applications, e.g., Taq polymerase in PCR applications, digestive enzymes in microbial degradative applications, etc.
Type:
Grant
Filed:
April 16, 2001
Date of Patent:
June 17, 2003
Assignee:
University of Maryland Biotechnology Institute
Abstract: A polypropylene composition and modified fibers thereof, includes polypropylene and an elastomer. The elastomer has a melting temperature of, at least, 80° C., preferably 100-180° C., a melt flow index in the range of 1-60 g/10-min., and a density within the range of 0.85-0.95 g/cm3. The elastomer is a branched copolymer of an ethylene copolymer, a polyolefin copolymer or a combination thereof, with ethylene, higher alkene groups, or both ethylene and higher alkene groups in the main chain of the branched copolymer, and with a weight proportion of polypropylene to elastomer being in the range of from 99.9:0.1 to 0.1:99.9. A method for producing the polypropylene composition and modified fibers thereof is also disclosed.
Type:
Grant
Filed:
April 18, 2000
Date of Patent:
June 10, 2003
Assignee:
Instytut Wlokien Chemicznych
Inventors:
Henryk Struszczyk, Karlina Grzebieniak, Alojzy Urbanowski, Arkadiusz Wilczek, Stanislaw Galecki, Jan Kazmierski, Konrad Kazmierski
Abstract: The present invention relates to a composition and method for enhancing the efficacy of a vaccine in a subject treated with the vaccine by administering to the subject an antigen in conjunction with a chemokine.
Type:
Grant
Filed:
June 12, 2000
Date of Patent:
May 27, 2003
Assignee:
University of Maryland Biotechnology Institute
Inventors:
Alfredo Garzino-Demo, Anthony L. DeVico
Abstract: A process and apparatus for purifying one or more target substances from a source liquid, employing one or more cross-flow filter elements, and one or more types of chromatography resins, in combination, to provide purification with advantageous yield, product purity, and cost- and time-efficiency.
Abstract: A method and apparatus for purifying aqueous effluent streams to reduce chemical oxygen demand thereof, where the method comprises direct oxidation of water-soluble organic material in an electrochemical cell that incorporates stainless steel electrodes, whose stability and lifetime are enhanced by inclusion of circulating metal chips.
Type:
Grant
Filed:
May 15, 2001
Date of Patent:
April 29, 2003
Inventors:
Clyde Kuen-Hua Hu, Paul Pei-Yung Hu, Patrick Pei-Chih Hu
Abstract: A method and system for retrofitting an integrated scrubber to provide maximum oxygen content in a controlled decomposition oxidation (CDO) abatement process. The system includes a thermal/wet integrated scrubber, and a compressed air supply for supplying air to an oxygen separation device that separates the air into a nitrogen-enriched component and an oxygen-enriched component. The oxygen separation device utilizes a ceramic oxide or polymeric material to separate from the supplied air an oxygen-enriched component for introduction into the integrated scrubber. The integrated scrubber is equipped with a mechanical scraping device for continuous or intermittent removal of combustion deposits formed during the controlled decomposition oxidation process.
Type:
Grant
Filed:
July 23, 2001
Date of Patent:
April 22, 2003
Assignee:
Advanced Technology Materials, Inc.
Inventors:
Belynda G. Flippo, Robbert Vermuellen, Daniel O. Clark
Abstract: The HIV-1 transactivator protein Tat significantly increases astrocytic expression and release of monocyte chemoattractant protein-1. Monocyte chemoattractant protein-1 (MCP-1) is expressed in the brains of patients with HIV-1-associated dementia, and is present in the cerebrospinal fluid of patients with this condition. This present invention employs compounds, such as MCP-1 antagonists and partial agonists, as well as HIV-1 Tat-inhibitors in methods for treating and/or preventing HIV-1 associated dementia.
Type:
Grant
Filed:
March 17, 1998
Date of Patent:
April 1, 2003
Assignee:
University of Maryland Biotechnology Institute
Abstract: Novel calcium free subtilisin mutants are taught, in particular subtilisins which have been mutated to eliminate amino acids 75-83 and which retain enzymatic activity and stability. Recombinant methods for producing same and recombinant DNA encoding for such subtilisin mutants are also provided.
Type:
Grant
Filed:
September 11, 2000
Date of Patent:
April 1, 2003
Assignee:
University of Maryland Biotechnology Institute